SYNC Syncona Limited

TIDMSYNC

RNS Number : 5324U

Syncona Limited

02 August 2022

Syncona Limited

Total Voting Rights

2 August 2022

Pursuant to DTR 5.6.1 Syncona Limited (the "Company") announces that as at 29 July 2022 the total number of ordinary shares in issue now stands at 669,329,324 and the total number of voting rights in the Company is 669,329,324 .

The Company does not hold any ordinary shares in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

[ENDS]

Enquiries

Syncona Ltd

Natalie Garland-Collins / Fergus Witt

Tel: +44 (0) 7714 916615

About Syncona

Syncona's purpose is to invest to extend and enhance human life. We do this by founding and building companies to deliver transformational treatments to patients in areas of high unmet need.

Our strategy is to found, build and fund companies around exceptional science to create a diversified portfolio of 15-20 globally leading healthcare businesses, across development stage and therapeutic areas, for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRFFFIITDILIIF

(END) Dow Jones Newswires

August 02, 2022 02:00 ET (06:00 GMT)

Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Nov 2023 a Dic 2023

Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Dic 2022 a Dic 2023